✦ LIBER ✦

Novel Long-Acting Crystal Formulation of Human Growth Hormone

✍ Scribed by Chandrika Govardhan; Nazer Khalaf; Chu W. Jung; Ben Simeone; Amy Higbie; Susan Qu; Letha Chemmalil; Sergey Pechenov; Sujit K. Basu; Alexey L. Margolin

Publisher: Springer US
Year: 2005
Tongue: English
Weight: 753 KB
Volume: 22
Category: Article
ISSN: 0724-8741
DOI: 10.1007/s11095-005-6021-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intranasal delivery of human growth horm

Intranasal delivery of human growth hormone: Optimization of formulation

✍ Kerstin Albertsson-Wikland; Lars Hedin; Peter Jansson; Sten Rosberg; Conny Wikst 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 669 KB

Novel antagonists of growth hormone-rele

Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers

✍ Anna Klukovits; Andrew V. Schally; Luca Szalontay; Irving Vidaurre; Andrea Papad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 877 KB

## Abstract ## BACKGROUND: Antagonists of growth hormone‐releasing hormone (GHRH) inhibit the proliferation of various human cancer cell lines and experimental tumors by mechanisms that include direct action on GHRH receptors in cancer cells. ## METHODS: In this study, the effects of newly synth

Bioavailability in human volunteers of t

Bioavailability in human volunteers of three intramuscular formulations of cefonicid: A long-acting cephalosporin

✍ W. Brumfitt; J. M. T. Hamilton-Miller; Deirdre Grady; I. James; Colette Price 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 1 views

Three different intramuscular formulations of cefonicid (a new long acting cephalosporin) have been tested for bioavailability in 12 healthy volunteers, using a triple crossover design. No significant differences were detectable between the bioequivalence of the three formulations in terms of area-u

The use of cortisone and of long-acting

The use of cortisone and of long-acting ACTH to assess the biological activity of the somatotropic hormone (growth hormone)

✍ I. A. Éskin; N. V. Mikhailova 📂 Article 📅 1959 🏛 Springer US 🌐 English ⚖ 436 KB

Pharmacokinetics of a long-acting bromoc

Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone

✍ E. Pozo; K. Schlüter; E. Nüesch; J. Rosenthaler; L. Kerp 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 529 KB

Long-term human growth hormone expressio

Long-term human growth hormone expression and partial phenotypic correction by plasmid-based gene therapy in an animal model of isolated growth hormone deficiency

✍ Nélio A. J. Oliveira; Cláudia R. Cecchi; Eliza Higuti; João E. Oliveira; Thomas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract ## Background A model for __in vivo__ gene therapy based on electroporation of human growth hormone (hGH)‐coding naked DNA in the muscle of dwarf (lit/lit) and immunodeficient dwarf (lit/scid) mice is described. ## Methods A plasmid containing the ubiquitin C promoter and the genomic